of KW-5805, a new antiulcer agent, on various experimental ulcers, necrotizing agent induced gastric lesions and gastric acid secretion in rats were compared with those of pirenzepine and cimetidine. KW-5805 showed antiulcer activities against experimental gastric and duodenal ulcers (ED50 =1 .2-10.0 mg/kg, p.o.). KW-5805 effectively inhibited gastric lesions induced by various necrotizing agents (ED50=4.5-39.8 mg/kg, p.o.). In addition, the cytoprotecive effect of KW-5805 was not affected by indomethacin, but reserved by N-ethylmaleimide. These antiulcer and cytoprotective effects of KW-5805 were more potent than those of pirenzepine and cimetidine. In pylorus-ligated rats, intraduodenal KW-5805 administration at 30 mg/kg showed a weak antisecretory effect, which was 3 -10 times less potent than those of pirenzepine and cimetidine. In rats with acute gastric fistula, intravenous injection of KW-5805 reduced methacholine-stimulated gastric acid secretion at doses of 10 and 30 mg/kg and inhibited tetragastrin-in duced acid secretion at 30 mg/kg. These results indicate that KW-5805 has potent and broad antiulcer prop erties, which are probably exerted by its potent cytoprotective effect in addition to its antisecretory effect.
It is generally accepted that peptic ulcers are caused by an imbalance of aggressive factors (acid and pepsin) and mucosal defensive factors (mucus, bicarbonate and blood flow) (1) . Consequently, antiulcer therapy has been main ly directed toward the aggressive factors. Histamine (H2) receptor antagonists, anticholinergics, and antacids are known to lower acid secretion (2) . Cimetidine, an H2-recep tor antagonist, is widely used for the treatment of peptic ulcers. Some tricyclic compounds such as doxepine, an antidepressant, and pirenzepine, a selective muscarinic receptor antagonist, exert antiulcerogenic effects mainly through antisecretory mechanisms (3 6) .
On the other hand, Robert (7) first introduced the term "cytoprotection" to describe the ability of prosta glandins (PGs) to protect against the development of gastric lesions induced by necrotizing agents, and this phenomenon is independent of the inhibition of acid secretion. Since it was reported that endogenous PGs and nonprotein sulfhydryls (NP-SHs) were involved in cytoprotection (8, 9) , many antiulcer compounds such as pirenzepine and the other antimuscarinic agents were found to elict inhibitory actions against gastric lesion models whose pathogeneses were unrelated to acid secre tion (10) (11) (12) . 5 ethyl] amino -5,11-dihydro [ 1 ] benz oxepino [3,4-b] pyridine trihydrochloride (KW-5805) is a newly synthesized tricyclic compound ( Fig. 1) , which ex hibits low affinity to the muscarinic acetylcholine recep tor as compared to pirenzepine and has antiulcer activity against experimental stress ulcer (13).
In the present study, we compared the antiulcer and cytoprotective properties of KW-5805 with those of pir enzepine and cimetidine. In addition, the cytoprotective effect of KW-5805 and its relationship to endogenous PGs and NP-SHs were studied. We also investigated the effect of KW-5805 on gastric acid secretion to clarify its mecha nism of action.
MATERIALS AND METHODS

Animals
Male Donryu rats (Nihon Rat, Urawa) weighing 190 210 g were used. The animals were housed under controlled environmental conditions (room temperature 22 26C and humidity 55 60%) and fed a standard diet (Funabashi Farmas, Funabashi).
Drugs
KW-5805 was synthesized in our laboratory. Other drugs and chemicals used were obtained from the follow ing sources: pirenzepine dihydrochloride (Chemofin, Milano, Italy); cimetidine (Ricerchimica, Milano, Italy); aspirin, indomethacin and methacholine chloride (Sigma, St. Louis, MO, USA); mepirizole (Daiichi, Tokyo); sodium taurocholate (Difco Lab., Detroit, MI, USA); tetragastrin (Teikokuzoki, Tokyo); 1 N HCl and N ethylmaleimide (Wako Pure Chem., Osaka); and ethanol (Kanto Chem., Tokyo).
KW-5805 and pirenzepine were dissolved in saline. Cimetidine was suspended in 0.3% carboxymethylcellu lose sodium (CMC; Daiichi Pure Chem., Tokyo). These drugs were given orally in a volume of 0.5 ml/ 100 g body weight.
Experimental gastroduodenal ulcers
Water-immersion stress-induced gastric ulcer: Animals were deprived of food but allowed free access to water for 17 hr before the experiment. According to the method of Takagi and Okabe (14) , each animal was placed in a re straint cage and then immersed in a water bath at 22-24°C. After 7 hr, the animals were sacrificed. The stomachs were removed and then cut along the greater cur vature. Drugs were administered orally 10 min before the water-immersion. The length (mm) of each ulcer formed on the glandular stomach was measured under a mag nifying glass (5 x ), and the sum of the lengths in each animal served as the measure of ulcer index.
Aspirin-induced gastric ulcer: Aspirin was suspended in 0.3% carboxymethylcellulose sodium (CMC) and ad ministered orally at a dose of 200 mg/kg to 48-hr fasted rats. The animals were sacrificed 20 hr after aspirin ad ministration. Drugs were administered orally 30 min be fore aspirin treatment. The ulcer index was assessed as described above.
Indomethacin-induced gastric ulcer: Indomethacin (20 mg/kg) suspended in 0.3 % CMC was administered to 48-hr fasted rats. The animals were sacrificed 20 hr after indomethacin administration. Drugs were administered orally 30 min before indomethacin treatment. The stomachs were excised and their ulcer index determined.
Mepirizole-induced duodenal ulcer: According to the previously reported method (15), the animals were fasted for 17 hr with access to water ad libitium. Mepirizole was suspended in 0.3% CMC and administered orally at a dose of 200 mg/kg. Drugs were given 30 min before mepirizole treatment. Twenty hours after mepirizole ad ministration, the duodenum of each animal was excised.
The area (mm2) of the ulcers were measured and summed. The total area per animal served as the measurement of ulcer index.
Experimental gastric lesions induced by necrotizing agents
Animals were fasted for 36 hr with access to drinking water ad libitium. The following necrotizing agents were administered orally in the volume of 1 ml: 99.5% ethanol, 0.6 N HCI, 0.5 N HCI + 50% ethanol (acidified ethanol), and 0.1 N sodium taurocholate + 0.2 N HCI, according to the method of Robert (7) and Konturek et al. (16) . Drugs were given orally 30 min prior to the treatment of necrotizing agents. In addition, KW-5805 was injected subcutaneously 30 min before ethanol treatment. Thirty minitues after the administration of necrotizing agents, the animals were sacrificed. The stomach was removed and cut along the greater curvature. The length (mm) of each necrotic lesion was measured under a magnifying glass (5 x ), summed per stomach, and used as a lesion in dex. In acidified ethanol-induced gastric lesion-tests, indo methacin, a cyclooxygenase inhibitor (5 mg/kg), or N ethylmaleimide, an SH blocker (5 mg/kg), was given sub cutaneously 1 hr before KW-5805 treatment. KW-5805 was given orally 30 min before acidified ethanol adminis tration.
Gastric secretion
Pylorus-ligated rats: Animals were fasted for 48 hr with access to water ad libitium. Drugs were given i.d. im mediately after the pylorus ligation under ether anesthe sia. Four hours after the pylorus ligation, the rats were sacrificed and the gastric contents were collected, its volume measured, centrifuged and subjected to analysis for titrable acidity against 0.05 N NaOH to pH 7.4 using a pH meter. The acid concentration was multiplied by the volume to obtain the total acid output.
Rats with acute fistula: Animals were deprived of food but allowed free access to water for 24 hr. Each animal was then anesthetized with urethane (1 mg/kg, i.p.) and surgically prepared as described by Sasajima et al. (17) . A small midline incision was made, and the stomach and duodenum were exposed. A dual polyethyl ene canula was inserted into the forestomach. Three milli liters of warm saline (371C) was perfused into the gastric lumen, and the perfusate was collected at the end of 1 hr and titrated for acidity with 0.05 N NaOH. The following secretagogues were administered subcutaneously: methacholine at 1 mg/kg, histamine at 30 mg/kg and tetragastrin at 0.3 mg/kg. Drugs were injected intra venously 30 min before each secretagogue treatment.
Satistical analysis
Data were presented as the mean ±S.E. The 50% effec tive dose (ED50) values of test drugs for experimental gas troduodenal ulcers and gastric lesions induced by various necrotizing agents were calculated according to Filler's theorem. Satistical analysis was performed by Student's t-test or Aspin-Welch test. A difference with a P value <0.05 was considered significant. 
RESULTS
Experimental gastroduodenal ulcers Oral administration of KW-5805 dose-dependently inhibited the development of gastric ulcers induced by stress, aspirin and indomethacin. KW-5805 was also effec tive for preventing duodenal ulcers produced by mepiri zole. The ED50 values of KW-5805 for each ulcer model ranged from 1.2 to 10 mg/kg (Table 1) . Pirenzepine and cimetidine also dose-dependently prevented the ulcers, but both drugs showed a weak antiulcer activity against indomethacin-induced gastric ulcer. The ED50 values are listed in Table 1 . Antiulcer effects of KW-5805 were 3 10 times more potent than those of pirenzepine and cimeti dine. lesions induced by ethanol; the lesion indices were 12±2 and l0--h2, respectively (Fig. 2 ). Subcutaneous treatment with indomethacin (5 mg/kg) or N-ethylmaleimide (5 mg/kg) did not affect acidified ethanol-induced gastric lesions. Pretreatment with indo methacin also did not influence the cytoprotective effect of KW-5805 against acidified ethanol-induced gastric mu cosal lesions; the lesion index (% of control) was 42±4 without and 40±5 with indomethacin.
N-Ethylmale imide, given subucutaneously at a dose of 5 mg/kg, signifi cantly reduced the protective effect of KW-5805 against the lesions; the lesion index (°Io of control) was 31 ±4 without and 56±7 with N-ethylmaleimide (Fig. 3) .
Gastric secretion KW-5805, only at dose of 30 mg/kg, significantly decreased the volume and acid output in the pylorus-ligat ed (4 hr) rats. Pirenzepine and cimetidine significantly reduced gastric acid secretion dose-dependently. The anti secretory effect of KW-5805 was about 3-10 times less potent than those of pirenzepine and cimetidine (Table  3) .
In rats with acute gastric fistula, KW-5805, adminis tered intravenously at 10 and 30 mg/kg, showed a signifi cant inhibition of methacholine-stimulated gastric acid secretion (Fig. 4) . Pirenzepine (1 and 3 mg/kg, i.p.) also inhibited methacholine-stimulated gastric acid secretion.
The antisecretory effect of KW-5805 at dose of 30 mg/kg was similar to that of pirenzepine at 1 mg/kg (Fig. 4) . KW-5805 at 30 mg/kg also reduced tetragastrin-stimu lated acid secretion, but did not affect histamine-induced secretion. The inhibitory effect of KW-5805 was weak as compared to that against methacholine-stimulated acid secretion (Fig. 5) . 
DISCUSSION
The present studies demonstrated that KW-5805 had marked antiulcer effects against various kinds of experi mental ulcers in rats. Its antiulcer activity was 3 10 times more potent than those of pirenzepine and cimetidine.
Production of gastric ulcers by stress and non-steroidal inflammatory drugs (NSAIDs) are thought to result from reinforcement of aggressive factors such as gastric acid and pepsin or lowering of mucosal defensive factors such as gastric mucus and microcirculation (18) (19) (20) (21) (22) (23) (24) (25) . Mepiri zole-induced duodenal ulcers in rats are markedly inhibit ed by antacids and antisecretory agents (26) . It is sup posed that gastric acid is a very important factor in the pathogenesis of gastric and duodenal ulcers. We, there fore, investigated the effect of KW-5805 on gastric secre tion. In pylorus-ligated rats, intraduodenal administra tion of KW-5805 at doses of 3 and 10 mg/kg did not affect gastric acid secretion, but showed a weak inhibitory effect at 30 mg/kg. It was disclosed that the inhibitory doses of KW-5805 against experimental gastrodudenal ulcers were lower than the dose at which it suppressed the gastric secretion in pylorus-ligated rats. It is most likely that the antiulcer effect of KW-5805 is exerted not only by inhibi tion of gastric acid secretion but also by activation of gas tric mucosal defensive factors. In fact, KW-5805 showed an increase of gastric mucus secretion and improved mu cosal microcirculation (27) . reported to be effective in the treatment of gastroduo denal ulcers by their antisecretory action mediated through blockade of muscarinic receptors or histamine H2-receptors and uptake inhibition of noradrenaline or serotonin (3, 4, 28, 29) . KW-5805, however, has a very weak musucarinic receptor binding (1/30 of pirenzepine) (13) and no effect on H2-receptors and noradrenaline up take (A. Ishii et al., unpublished data). The mode of the antisecretory action of KW-5805 is thus apparently differ ent from those of cimetidine and tricyclic antidepressants and may be mediated at least partly through its weak an timuscarinic action as compared to pirenzepine. Further more, it is likely that the inhibitory effect of KW-5805 on gastric acid secretion is mediated by its effect on parietal cells or enterochromaffin-like (ECL) cells in the stomach, since gastrin stimulates acid secretion directly mediated by the gastrin receptors on parietal cells (30) or indirectly mediated by the stimulation of endogenous histamine re lease from ECL cells (31) . It has also been reported that KW-5805 inhibits gastric acid secretion stimulated by 2 deoxy-D-glucose, mainly via centrally mediated mecha nisms (32) , and would be beneficial for the prevention of stress-induced gastric ulceration, which is closely associat ed with an increase in acid secretion (19) . The antisecre tory activity of KW-5805 is suggested to be partly involved in its antiulcer effects.
KW-5805 exerted inhibitory effects on various gastric mucosal lesions caused by necrotizing agents, and an espe cially marked effect was observed in ethanol-induced le sions. This effective dose of KW-5805 was lower than that for its antisecretory effect in pylorus-ligated rats. These findings indicate that KW-5805, like prostaglandins, has a "cytoprotective" effect according to the definition of Robert (7) . It seems likely that KW-5805 shows such a cytoprotective effect mainly through a systemic action be cause both oral and subcutaneous administration of KW 5805 were effective. The cytoprotection of KW-5805 was not induced through the mechanism of a mild irritant. Oral administration of pirenzepine also inhibited the ethanol-induced lesions, although these effective doses were higher than that of KW-5805. The protective doses of pirenzepine were similar to its antisecretory doses. Cimetidine at the antisecretory dose inhibited the gastric lesions induced by acidified taurocholate; and at the non antisecretory dose, it did not inhibit ethanol and HCl induced gastric lesions. These results suggest that there is a possibility that the inhibition of necrotizing agents-in duced gastric lesions by pirenzepine and cimetidine may be related to their antisecretory effects.
The inhibition of PGs synthesis by pretreatment with indomethacin did not antagonize the protective effect of KW-5805 against acidified ethanol-induced lesions. This result suggests that the effect of KW-5805 is not mediated by synthesis of cytoprotective PGs. In addition to PGs, NP-SHs are also involved in cytoprotection (9) . Pretreat ment with N-ethylmaleimide, resulting from decreased lev els of endogenous SHs, significantly suppressed the inhibi tory effect of KW-5805 against acidified ethanol-induced gastric lesion. This result suggests that endogenous SHs may be partly involved in the mechanism of gastric cyto protection afforded by KW-5805.
In conclusion, these results indicate that KW-5805 has potent and broad antiulcer properties, which depend not only on its anisecrtory effect but also on its enhancement of gastric mucosal defensive factors.
